Skip to main content
. Author manuscript; available in PMC: 2017 Oct 24.
Published in final edited form as: Hepatoma Res. 2017 May 9;3:79–85. doi: 10.20517/2394-5079.2017.06

Table 2.

3-year and 5-year overall survival after LT, HR, and RFA

Survival LT HR RFA HR/RFA
3-year OS 82.6% 62.5% 34.5% 40.8%
5-year OS 73.9% 56.3% 27.3% 33.8%

LT: liver transplantation; HR: hepatic resection; RFA: radiofrequency ablation; OS: overall survival